OBJECTIVE:Lifestyle intervention is not always effective for improving arterial hypertension and other cardiovascular risk factors, and the parameters determining the outcome are not known. Because high cardiorespiratory fitness (CRF) protects from cardiovascular disease and mortality, we determined whether CRF at baseline predicts the improvement of blood pressure and other cardiovascular risk factors during a lifestyle intervention. METHODS: A total of 219 patients at risk for type 2 diabetes, who underwent a 9-month lifestyle intervention with diet modification and increase in physical activity, and had measurement of CRF, were studied. Insulin sensitivity was estimated during a 75-g oral glucose tolerance test. Total body, visceral and liver fat were measured by magnetic resonance (MR) tomography and H-MR spectroscopy. CRF was estimated using two different methods, an incremental cycle exercise (maximal aerobic capacity-VO2max) test and a motorized treadmill (individual anaerobic threshold) test. RESULTS: After 9 months of intervention adiposity, glycemia, CRF, insulin sensitivity, SBP and serum lipids (except high-density lipoprotein cholesterol, P = 0.65) improved (all other P ≤ 0.006). DBP did not change significantly (P = 0.06). High CRF at baseline predicted decreases in SBP (P ≤ 0.0002) and DBP (P ≤ 0.004), and increase in insulin sensitivity (P ≤ 0.04), but not change in serum lipids (all P ≥ 0.06). For 1 SD increase in baseline CRF the odds ratio for resolution of hypertension or prehypertension was 2.26 (individual anaerobic threshold; 95% CI 1.40-3.80) and 1.75 (VO2max; 95% CI 1.08-2.89). CONCLUSION:CRF at baseline predicts the effectiveness of a lifestyle intervention in improving insulin sensitivity, and particularly blood pressure.
RCT Entities:
OBJECTIVE: Lifestyle intervention is not always effective for improving arterial hypertension and other cardiovascular risk factors, and the parameters determining the outcome are not known. Because high cardiorespiratory fitness (CRF) protects from cardiovascular disease and mortality, we determined whether CRF at baseline predicts the improvement of blood pressure and other cardiovascular risk factors during a lifestyle intervention. METHODS: A total of 219 patients at risk for type 2 diabetes, who underwent a 9-month lifestyle intervention with diet modification and increase in physical activity, and had measurement of CRF, were studied. Insulin sensitivity was estimated during a 75-g oral glucose tolerance test. Total body, visceral and liver fat were measured by magnetic resonance (MR) tomography and H-MR spectroscopy. CRF was estimated using two different methods, an incremental cycle exercise (maximal aerobic capacity-VO2max) test and a motorized treadmill (individual anaerobic threshold) test. RESULTS: After 9 months of intervention adiposity, glycemia, CRF, insulin sensitivity, SBP and serum lipids (except high-density lipoprotein cholesterol, P = 0.65) improved (all other P ≤ 0.006). DBP did not change significantly (P = 0.06). High CRF at baseline predicted decreases in SBP (P ≤ 0.0002) and DBP (P ≤ 0.004), and increase in insulin sensitivity (P ≤ 0.04), but not change in serum lipids (all P ≥ 0.06). For 1 SD increase in baseline CRF the odds ratio for resolution of hypertension or prehypertension was 2.26 (individual anaerobic threshold; 95% CI 1.40-3.80) and 1.75 (VO2max; 95% CI 1.08-2.89). CONCLUSION: CRF at baseline predicts the effectiveness of a lifestyle intervention in improving insulin sensitivity, and particularly blood pressure.
Authors: Ilia Kritikou; Maria Basta; Rafel Tappouni; Slobodanha Pejovic; Julio Fernandez-Mendoza; Racha Nazir; Michelle L Shaffer; Duanping Liao; Edward O Bixler; George P Chrousos; Alexandros N Vgontzas Journal: Eur Respir J Date: 2012-06-27 Impact factor: 16.671
Authors: Nelo Eidy Zanchi; Felipe Natali Almeida; Fábio Santos Lira; José César Rosa Neto; Humberto Nicastro; Claudia Ribeiro da Luz; Mário Alves de Siqueira Filho; Vitor Felitti; Mariz Vainzof; Marilia Seelaender; Jacques R Poortmans; Antonio Herbert Lancha Journal: ScientificWorldJournal Date: 2012-05-03
Authors: Leonor Guariguata; Ingrid de Beer; Rina Hough; Pancho Mulongeni; Frank G Feeley; Tobias F Rinke de Wit Journal: PLoS One Date: 2015-07-13 Impact factor: 3.240
Authors: M T Haren; G Misan; J F Grant; J D Buckley; P R C Howe; A W Taylor; J Newbury; R A McDermott Journal: Nutr Diabetes Date: 2012-01-16 Impact factor: 5.097
Authors: Ansgar Thiel; Gorden Sudeck; Hannes Gropper; Felipe Mattioni Maturana; Tanja Schubert; Duangkamol Srismith; Manuel Widmann; Simone Behrens; Peter Martus; Barbara Munz; Katrin Giel; Stephan Zipfel; Andreas Michael Nieß Journal: Contemp Clin Trials Commun Date: 2019-12-17